Vanderbilt-Ingram Cancer Ctr — Nashville, Tennessee

Vanderbilt-Ingram Cancer Ctr is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Ctr has participated in 14 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Carcinoma, Pancreatic Cancer, Malignant Melanoma.

Sponsors: Bristol-Myers Squibb, Merrimack Pharmaceuticals, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Ctr?

Vanderbilt-Ingram Cancer Ctr has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Ctr conducted?

Vanderbilt-Ingram Cancer Ctr has 14 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma, Pancreatic Cancer, Malignant Melanoma.

Is Vanderbilt-Ingram Cancer Ctr accredited by Crixeo Clinical Trials?

Vanderbilt-Ingram Cancer Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.